Photocure Asa
🇸🇪Sweden
Clinical Trials
11
Active:11
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
4
NMPA:1
CANADA:1
CIMA_AEMPS:1
Drug Approvals
Hexaminolevulinate Hydrochloride For Intravesical Solution
- Product Name
- 灌注用盐酸氨酮戊酸己酯
- Approval Number
- 国药准字HJ20240119
- Approval Date
- Oct 29, 2024
NMPA
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)No trials found
News
Hexvix Receives Marketing Approval in China for Bladder Cancer Detection
Asieris Pharmaceuticals' partner, Jiangsu Yahong Meditech, has received marketing approval from China's National Medical Products Administration (NMPA) for Hexvix.
Asieris Pharmaceuticals' Cevira (APL-1702) Shows Promise in HSIL Treatment: Phase III Subgroup Analysis
Asieris Pharmaceuticals presented Phase III trial subgroup analysis of Cevira (APL-1702) at the 2024 CSCO Annual Meeting, focusing on age-related efficacy in treating cervical HSIL.
Photocure and Karl Storz Launch Advanced Blue Light Cystoscopy System in US Market
Photocure ASA announces the commercial availability of Karl Storz's New Blue Light equipment powered by Saphira technology in the United States for bladder cancer detection.